MDA-7/IL-24-Based Cancer Gene Therapy: Translation from the Laboratory to the Clinic
Journal:
Current Gene Therapy
Volume:
6
Page:
73-91
Author(s):
Satoshi Inoue, Manish Shanker, Ryo Miyahara, Began Gopalan, Suraag Patel, Yasuhisa Oida, Cynthia D. Branch, Anupama Munshi, Raymond E. Meyn, Michael Andreeff, Fumihiro Tanaka, Abner M. Mhashilkar, Sunil Chada and Rajagopal Ramesh
Pulmonary Surfactant Proteins A and D: Innate Immune Functions and Biomarkers for Lung Diseases
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
589-598
Author(s):
Hiroki Takahashi, Hitomi Sano, Hirofumi Chiba and Yoshio Kuroki
In Vitro and In Vivo Sirolimus for Modulation of Allogeneic Hematopoietic Stem Cell Transplantation
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
5
Page:
555-564
Author(s):
Daniel H. Fowler and Ronald E. Gress
Are Selenoproteins Important for the Cancer Protective Effects of Selenium?
Journal:
Current Nutrition & Food Science
Volume:
1
Page:
201-214
Author(s):
Cindy D. Davis and Robert Irons
Folate Receptor Targeted Liposomes
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
547-552
Author(s):
Angelo P. Amico, Ilaria Covelli and Pietro Fiore
Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3531-3543
Author(s):
F. Saleh, I. Klepacek, G. Ibrahim, H. Dashti, S. Asfar, A. Behbehani, H. Al-Sayer and A. Dashti
Modulating Fatty Acid Metabolism and the AMP-Activated Protein Kinase Pathway as a Target for Obesity Therapy
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
5
Page:
439-450
Author(s):
E.- K. Kim, L. E. Landree, F. P. Kuhajda and G. V. Ronnett
New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
393-419
Author(s):
Christian Hafner, Albrecht Reichle and Thomas Vogt
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Journal:
Current Drug Targets
Volume:
6
Page:
665-682
Author(s):
K. Fjeldstad and S. O. Kolset
An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
2
Page:
325-343
Author(s):
L. A. Beltz and K. P. Manfredi